Nowadays, there are variable methods for editing specific sites in the E.coli chromosome. It is feasible, in a short period of time, either to perform gene-size (~1kb) integration into a single site or to introduce deletions, short insertions or point mutations into multiple sites. However, a method for rapidly integrating multiple gene-size sequences into different sites is not developed yet. Here, we describe a method and plasmid system to simultaneously insert genes into multiple specific loci of the E. coli genome without the need for chromosomal markers. The method uses a CRISPR-Cas12a system to eliminate unmodified cells by double stranded DNA cleavage and phage-derived recombinases, λ-Red, to facilitate recombination between the chromosome and donor DNA. We achieved the insertion of up to 3 heterologous genes in one round of recombination and selection. To demonstrate the practical application of this gene-insertion method, we constructed a high-yield recombinant E.coli producing an industrially useful chemical, 5-aminolevulinic acid (ALA). Moreover, a similar two-plasmid system was built to edit the genome of extremophile Halomonas bluephagenesis.
No takes yet. Share an insight, caveat, or question.
Ao et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: